Overall volume of digital payments in Mena has grown nearly seven-fold since 2020
business16 hours ago
MADA UV Company, a leader in in designing and manufacturing modern disinfection devices utilizing Ultraviolet sterilisation technology, showcased its latest innovation maximizing the outcome of UVC rays, designed to significantly impact the mortality & morbidity rate associated with surgical operations.
British laboratory tests confirm that the new device has successfully eradicated 930 of germs suspended in the air and on surfaces.
This design technology extends its sterilizing ability to operation room air and even ceilings, and is accordingly named “3D sterilization”. This innovation is anticipated to revolutionize current practices and set a new standard in the realm of healthcare facilities’ safety.
The device’s usage of mixed high-intensity Ultraviolet type-C rays has proven essential in swiftly neutralizing viruses and bacteria, including the COVID-19 virus which can be killed in a record time of few seconds. In fact, this technology can even eradicate notoriously antibiotic-resistant germs, such as Clostridium.
This device surpasses the limitations of conventional disinfection devices. Its ability to effectively reach and disinfect even the most challenging spots within operation rooms underscores its efficiency and speed.
MADA UV Chief Executive Officer Dr. Ahmad Alshalabi said that all hospital visitors carry some pathogens that will accumulate in the surgical environment over time. He stressed that incorporating UV-C disinfection technology into the mandatory protocol for surgical room disinfection is critical to ensuring the safety of patients by preventing the spread of bacteria and viruses, particularly in the current landscape of evolving pathogens with increasing resistance to conventional medicine.
Driven by the imperative to address the challenges posed by the COVID-19 pandemic, Dr. Alshalabi reveals that this technology would have drastically diminished the morbidity and mortality rates caused by any cross-infection in healthcare facilities, and since COVID-19 is one of the easiest viruses to be killed by UV-C light, he further emphasizes the necessity of incorporating this technology in disinfection protocol before and after every patient. Dr. Alshalabi states: “COVID-19 has urged us to design and manufacture devices that are capable of combating this virus effectively, in the hopes that we can save as many lives as possible. We are dedicated to continuously innovating solutions that will improve our healthcare environments, and ensure the safety of our patients.”
Further attesting to the device’s efficacy, Dr. Alshalabi highlights its impeccable performance in multiple laboratories. The device achieved a staggering 930 effectiveness in the distinguished Stanger lab, and, a remarkable 99.99930 effectiveness in eliminating all microbes in Dubai Government Central Labs.
Overall volume of digital payments in Mena has grown nearly seven-fold since 2020
business16 hours ago
In 2023, total consumption of gold in the UAE reached 39.7 tonnes
business1 day ago
Maritime India Vision 2030 envisions investment of Rs1.25 trillion
business1 day ago
Profitability, cash flow and capital expenditure guidance reiterated
business1 day ago
Swiss pharma firm has an annual capacity of 250 million tablets
business1 day ago
The total income for the period was Dh791.88 million
business1 day ago
As per the chairman of the UAE Banks Federation, the corporate tax in the Emirates is quite low compared to other countries
business1 day ago
Foreign investors took out more than $2 billion from Indian equities last week
business1 day ago